Live
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
- UP: Police officers, govt doctors to appear virtually in courts
- White tigress Sneha dies at Nandankanan zoo
- World Liver Day 2024: Follow these easy lifestyle tips to cleanse and maintain a healthy liver
Trump 'simply wrong' about Oct vaccine: Lancet editor
Trump ‘simply wrong’ about Oct vaccine: Lancet editor
Medical journal The Lancet's chief editor has said that US President Donald Trump's statement that a Covid-19 vaccine could be delivered by the end of October is "simply wrong."
New York : Medical journal The Lancet's chief editor has said that US President Donald Trump's statement that a Covid-19 vaccine could be delivered by the end of October is "simply wrong."
In a Skype interview with CNN, Richard Horton, editor-in-chief of The Lancet, said there will not be a vaccine available for public use by the end of October and President Trump is simply wrong about that.
"If we make a mistake and licence a vaccine too early - just think - we have already got a growing anti-vaccine movement, which is extremely disturbing. We can't cut corners. There will not be a vaccine available for public use by the end of October," Horton was quoted as saying to CNN.
"President Trump is simply wrong about that. I have no understanding why he is saying it. Because his advisers will surely be telling him that that's just impossible," Horton added.
Horton also said the results of a Russian-developed vaccine are "encouraging" but that it would be "highly premature to think that this is the basis for a successful vaccine for public use," in part since its study involved a very small number of volunteers.
